-
Why Did SVB Leerink Initiate Humana With Outperform?
Monday, September 27, 2021 - 10:40am | 315Read More...While Humana Inc.’s (NYSE: HUM) stock already seems to price in the near-term concerns around rebounding medical costs and high COVID-19 costs, it offers an opportunity to gain exposure to “the post-COVID accelerating growth environment and associated 2022 inflection,” according...
-
Analysts Offer Positive Prognosis For UnitedHealth After Investor Day
Wednesday, December 4, 2019 - 1:10pm | 638Read More...UnitedHealth Group Inc (NYSE: UNH) plummeted ahead of Tuesday’s investor day and failed to recover throughout the session. However, analysts walked away from the presentation more bullish on the stock. “The investor day reinforced our thesis that we believe EPS visibility is high for...
-
5 Reasons The Prognosis For Acadia Healthcare Just Got Worse
Wednesday, October 25, 2017 - 10:24am | 350Read More...Shares of Acadia Healthcare Company Inc (NASDAQ: ACHC) plummeted 25 percent after the behavioral healthcare services company with operations in the U.S. and U.K. reported disappointing third-quarter earnings. In reaction to the earnings report, Baird's Whit Mayo downgraded Acadia's stock...
-
Look Closer, Tenet Healthcare Is Making More Progress Than It Seems
Tuesday, August 8, 2017 - 1:46pm | 409Read More...At first glance, Baird said Tenet Healthcare Corp (NYSE: THC)'s second-quarter result is better than it looks. The firm clarified that the optics of the print, guide-down and complexity once again overshadowed progress. Overall In-Line Results Analyst Whit Mayo noted Tenet Healthcare's second-...
-
Birth Trends Are Not Mednax's Friend; Baird Downgrades
Tuesday, March 21, 2017 - 1:33pm | 339Read More...Shares of MEDNAX Inc (NYSE: MD) have recovered from their steep downturn in response to the company’s lower-than-expected fourth-quarter 2016 results. Although Street expectations do not appear “as ambitious as prior years,” the company’s organic growth is likely to be...
-
Baird Prescribes An Upgrade For Community Health As Planned Asset Sales Should Ease Leverage
Thursday, February 23, 2017 - 1:11pm | 333Read More...Baird analyst Whit Mayo has upgraded Community Health Systems (NYSE: CYH) to Neutral from Underperform, saying the planned asset sales should ease leverage. Community Health is shopping 25 hospitals, 15 of which have definitive agreements to be sold and 10 of which have signed LOIs. These...
-
3 Reasons Baird Downgraded Laboratory Corp Of America
Monday, February 6, 2017 - 1:57pm | 396Read More...Baird downgraded Laboratory Corp. of America Holdings (NYSE: LH) to Neutral amid reports that the company in among the bidders for clinical trials firm Pharmaceutical Product Development Inc. Analyst Whit Mayo put out the following three reasons for the downgrade: (1) “we're less...
-
Community Health Systems Could Have Trouble Finding Strategic Buyers
Monday, September 19, 2016 - 11:46am | 388Read More...On September 16, Bloomberg reported that Community Health Systems (NYSE: CYH)'s board was evaluating strategic alternatives, which included a sale of the company. Baird’s Whit Mayo maintains a Neutral rating on the company, with a price target of $12. Strategic Buyers Unlikely “In our...
-
Baird: Acadia Healthcare Should Sustain High-Single-Digit Same-Store Revenue Growth
Tuesday, June 14, 2016 - 11:02am | 309Read More...Acadia Healthcare Company Inc (NASDAQ: ACHC) should sustain high-single-digit same-store revenue growth on recent momentum and high visibility around new bed additions, according to a note from Baird. Analyst Whit Mayo reiterated his Outperform rating on the stock as he feels "1) 2Q feels like it's...
-
Addus HomeCare Corp. (ADUS) Maintains Outperform Rating
Monday, March 29, 2010 - 12:35pm | 114Read More...Analysts Whit Mayo and Matthew Gillmor at Baird have released an update on Addus HomeCare Corp. (NASDAQ: ADUS). Analysts believe that the state of disarray within Illinois is currently at its peak, but not getting better. According to analysts, on the positive side, the state has a new internal...
-
Universal Health Services (UHS) Price Target Raised To $41
Monday, March 1, 2010 - 10:03am | 159Read More...Baird analysts Whit Mayo and Matthew Gillmor reiterated their Outperform rating for shares of Universal Health Services, Inc. (NYSE: UHS) and raised their price target from $40 to $41. The Baird analysts said that guidance was positive and commented that, "adjusted for $0.18 in lost earnings from...
